Company Filing History:
Years Active: 2024
Title: Harry Robert Lester - Innovator in Drug Delivery Technology
Introduction
Harry Robert Lester is a notable inventor based in London, GB. He has made significant contributions to the field of drug delivery devices, showcasing his innovative spirit through his patented inventions. With a focus on enhancing medical technology, Lester's work is pivotal in improving patient care.
Latest Patents
Lester holds a patent for a "Needle hub with pressure interlock for drug delivery device." This invention features a needle hub that includes a needle holder and a needle attached to it. The device is equipped with a needle actuation assembly that allows the needle holder to move between a retracted position and an insertion position. A key component of this invention is the pressure interlock, which comprises an inlet for fluid communication with a fluid source, an outlet connected to the needle, and a lock member. The lock member operates in two positions: one that prevents actuation of the needle actuation assembly and another that allows it. The transition between these positions is controlled by the pressure within the interlock, ensuring safe and effective drug delivery.
Career Highlights
Harry Robert Lester is currently associated with Becton Dickinson and Company Limited, a leading global medical technology company. His role at Becton Dickinson highlights his commitment to advancing healthcare solutions through innovative design and engineering.
Collaborations
Lester has collaborated with notable colleagues, including Steve Beguin and Patrick Le Gal Redon. These partnerships reflect a collaborative approach to innovation, fostering an environment where ideas can flourish and lead to groundbreaking advancements in medical technology.
Conclusion
Harry Robert Lester's contributions to drug delivery technology exemplify the impact of innovation in healthcare. His patented inventions are a testament to his dedication to improving patient outcomes through advanced medical devices.